Hypothalamo-pituitary-adrenal function in Parkinsonian patients treated with melatonin

References

• Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. The effect of melatonin upon human brain. Life Sci 1971; 10: 8411. Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. The effect of melatonin upon human brain. Life Sci 1971; 10: 841
   Web of Science ®Google Scholar
• Boyd A. E., Lebovitz H. E., Feldman J. M. Endocrine function in patients with Parkinson's disease and their alteration by L-dopa. J. Clin. Endocrinol. Metab 1971; 33: 8292. Boyd A. E., Lebovitz H. E., Feldman J. M. Endocrine function in patients with Parkinson's disease and their alteration by L-dopa. J. Clin. Endocrinol. Metab 1971; 33: 829
   PubMed Web of Science ®Google Scholar
• Eddy R. L., Jones A. L., Chakmakjian Z. H., Silverthorne M. C. Effect of levodopa on human hypophyseal trophic hormone release. J. Clin. Endocrinol. Metab 1971; 33: 43. Eddy R. L., Jones A. L., Chakmakjian Z. H., Silverthorne M. C. Effect of levodopa on human hypophyseal trophic hormone release. J. Clin. Endocrinol. Metab 1971; 33: 4
   Google Scholar
• The Pineal. Lancet 1974; 2: 12354. The Pineal. Lancet 1974; 2: 1235
   PubMedGoogle Scholar
• Fraschini F., Martini L. Rhythmic phenomena and pineal principles. “The Hypothalamus”. Academic Press, New York and London 1970; 5295. Fraschini F., Martini L. Rhythmic phenomena and pineal principles. “The Hypothalamus”. Academic Press, New York and London 1970; 529
   Google Scholar
• James V. H. T., Landon J. Control of corticosteroid secretion—current views and methods of assessment. “Recent Advances in Endocrinology”, 8th Edition, V. H.T. James. Churchill, London 1969; 506. James V. H. T., Landon J. Control of corticosteroid secretion—current views and methods of assessment. “Recent Advances in Endocrinology”, 8th Edition, V. H.T. James. Churchill, London 1969; 50
   Google Scholar
• Motta M., Schiaffini O., Piva F., Martini L. Pineal principles and the control of adrenocorticotrophin secretion. “The Pineal Gland” Ciba Foundation Symposium. 1971, G. E.W. Wolstenholme, Julie Knight. Churchill-Livingstone, London, 2797. Motta M., Schiaffini O., Piva F., Martini L. Pineal principles and the control of adrenocorticotrophin secretion. “The Pineal Gland” Ciba Foundation Symposium. 1971, g. E.W. Wolstenholme, Julie Knight. Churchill-Livingstone, London, 279
   Google Scholar
• Papavasilou P. S., Cotzias G. C., Düby S. E., Steck A. J., Bell M., Lawrence W. H. Melatonin and Parkinsonism. J.A.M.A 1973; 221: 888. Papavasilou P. S., Cotzias g. C., Düby S. E., Steck A. J., Bell M., Lawrence W. H. Melatonin and Parkinsonism. J.A.M.A 1973; 221: 88
   Web of Science ®Google Scholar
• Shaw K. M. A review of the biochemistry, physiology and pharmacological potential of melatonin and other pineal substances. “Advances in Drug Research”, A. Simmonds. Academic Press, London 1976; 119. Shaw K. M. A review of the biochemistry, physiology and pharmacological potential of melatonin and other pineal substances. “Advances in Drug Research”, A. Simmonds. Academic Press, London 1976; 11
   Google Scholar
• Shaw K. M., Stern G. M., Sandler M. Melatonin and Parkinsonism. Lancet 1973; 1: 27110. Shaw K. M., Stern g. M., Sandler M. Melatonin and Parkinsonism. Lancet 1973; 1: 271
   PubMed Web of Science ®Google Scholar
• Shaw K. M., Stern G. M., Sandler M. Melatonin and metatyrosine in the treatment of Parkinsonism. “Advances in Neurology”, D. Calne. Raven Press. 1973; 3: 11511. Shaw K. M., Stern g. M., Sandler M. Melatonin and metatyrosine in the treatment of Parkinsonism. “Advances in Neurology”, D. Calne. Raven Press. 1973; 3: 115
   Google Scholar
• Sirtori C. R., Bolme P., Azarnoff D. L. Metabolic responses to acute and chronic L-dopa administration in patients with Parkinsonism. N. Engl. J. Med 1972; 287: 72912. Sirtori C. R., Bolme P., Azarnoff D. L. Metabolic responses to acute and chronic L-dopa administration in patients with Parkinsonism. N. Engl. J. Med 1972; 287: 729
   PubMed Web of Science ®Google Scholar
• Von Werder K., Van Loon G. R., Yatsu F., Forsham P. H. Corticosteroid and growth hormone secretion in patients treated with L-dopa. Klin. Wochenschr 1970; 48: 145413. Von Werder K., Van Loon g. R., Yatsu F., Forsham P. H. Corticosteroid and growth hormone secretion in patients treated with L-dopa. Klin. Wochenschr 1970; 48: 1454
   PubMedGoogle Scholar
• Wilcox C. S., Aminoff M. J., Millar J. g. B., Keenan J., Kremer M. Circulating levels of corticotrophin and cortisol after infusions of L-dopa, dopamine and noradrenaline in man. Clin. Endocrinol 1975; 4: 19114. Wilcox C. S., Aminoff M. J., Millar J. g. B., Keenan J., Kremer M. Circulating levels of corticotrophin and cortisol after infusions of L-dopa, dopamine and noradrenaline in man. Clin. Endocrinol 1975; 4: 191
   PubMed Web of Science ®Google Scholar
• Wurtman R. J. The pineal gland; endocrine inter-relationships. Adv. Intern. Med 1970; 16: 15515. Wurtman R. J. The pineal gland; endocrine inter-relationships. Adv. Intern. Med 1970; 16: 155
   PubMedGoogle Scholar
• Wurtman R. J., Axelrod J., Kelly D. E. “The Pineal”. Academic Press, New York and London 196916. Wurtman R. J., Axelrod J., Kelly D. E. “The Pineal”. Academic Press, New York and London 1969
   Google Scholar